📰 Abt News
Page 87 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
October 8, 2023
Arlington Partners LLC increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 132.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,113 shares of the healthcare product maker’s stock after purchasing an additional 1,773 shares during the quarter. Arlington Partners LLC’s holdings […]
October 8, 2023
Albion Financial Group UT boosted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 33.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,191 shares of the healthcare product maker’s stock after purchasing an additional 550 shares during the quarter. Albion Financial […]
October 8, 2023
Plancorp LLC boosted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 18,220 shares of the healthcare product maker’s stock after purchasing an additional 344 shares during the quarter. Plancorp LLC’s holdings […]
October 8, 2023
Cahaba Wealth Management Inc. cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 4.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,828 shares of the healthcare product maker’s stock after selling 232 shares during the period. Cahaba […]
October 8, 2023
Cypress Capital Group lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.8% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 80,144 shares of the healthcare product maker’s stock after selling 1,492 shares during the period. Abbott […]
October 8, 2023
Janney Montgomery Scott LLC bought a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 601,047 shares of the healthcare product maker’s stock, valued at approximately $65,526,000. A number of other institutional investors […]
October 8, 2023
Patten Group Inc. lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 3.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,803 shares of the healthcare product maker’s stock after selling 318 shares during the period. Patten Group Inc.’s holdings in Abbott Laboratories […]
October 8, 2023
National Bank of Canada FI increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 17.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,009,436 shares of the healthcare product maker’s stock after purchasing an additional 149,087 shares during the period. […]
October 8, 2023
Patten Group Inc. decreased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 3.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,803 shares of the healthcare product maker’s stock after selling 318 shares during the quarter. Patten […]
October 8, 2023
Patten Group Inc. trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 3.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,803 shares of the healthcare product maker’s stock after selling 318 shares during the period. Patten […]